ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rotavirus Infections Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18H9477
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Rotavirus Infections Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Rotavirus Infections Drug Market Research Report 2025

Code: QYRE-Auto-18H9477
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
CureVac
Medicago
Nanotherapeutics Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Institute of Biological Products Co Ltd

Rotavirus Infections Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rotavirus Infections Drug Market

Rotavirus Infections Drug Market

The global market for Rotavirus Infections Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rotavirus Infections Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Infections Drug.
The Rotavirus Infections Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rotavirus Infections Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Infections Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rotavirus Infections Drug Market Report

Report Metric Details
Report Name Rotavirus Infections Drug Market
CAGR 5%
Segment by Type
  • RV-3BB
  • RV-625
  • UMN-2001
  • Rotavac-5C
  • Others
Segment by Application
  • Clinic
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Biological E Ltd, Curevac AG, Medicago Inc, Nanotherapeutics Inc, Serum Institute of India Ltd, UMN Pharma Inc, Wuhan Institute of Biological Products Co Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rotavirus Infections Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rotavirus Infections Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rotavirus Infections Drug Market report?

Ans: The main players in the Rotavirus Infections Drug Market are Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Biological E Ltd, Curevac AG, Medicago Inc, Nanotherapeutics Inc, Serum Institute of India Ltd, UMN Pharma Inc, Wuhan Institute of Biological Products Co Ltd

What are the Application segmentation covered in the Rotavirus Infections Drug Market report?

Ans: The Applications covered in the Rotavirus Infections Drug Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Rotavirus Infections Drug Market report?

Ans: The Types covered in the Rotavirus Infections Drug Market report are RV-3BB, RV-625, UMN-2001, Rotavac-5C, Others

Recommended Reports

Infection Drug Markets

Virus and Vaccine Markets

Infectious Disease Diagnostics

1 Rotavirus Infections Drug Market Overview
1.1 Product Definition
1.2 Rotavirus Infections Drug by Type
1.2.1 Global Rotavirus Infections Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 RV-3BB
1.2.3 RV-625
1.2.4 UMN-2001
1.2.5 Rotavac-5C
1.2.6 Others
1.3 Rotavirus Infections Drug by Application
1.3.1 Global Rotavirus Infections Drug Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Rotavirus Infections Drug Market Size Estimates and Forecasts
1.4.1 Global Rotavirus Infections Drug Revenue 2020-2031
1.4.2 Global Rotavirus Infections Drug Sales 2020-2031
1.4.3 Global Rotavirus Infections Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rotavirus Infections Drug Market Competition by Manufacturers
2.1 Global Rotavirus Infections Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rotavirus Infections Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rotavirus Infections Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rotavirus Infections Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rotavirus Infections Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rotavirus Infections Drug, Product Type & Application
2.7 Global Key Manufacturers of Rotavirus Infections Drug, Date of Enter into This Industry
2.8 Global Rotavirus Infections Drug Market Competitive Situation and Trends
2.8.1 Global Rotavirus Infections Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rotavirus Infections Drug Players Market Share by Revenue
2.8.3 Global Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rotavirus Infections Drug Market Scenario by Region
3.1 Global Rotavirus Infections Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rotavirus Infections Drug Sales by Region: 2020-2031
3.2.1 Global Rotavirus Infections Drug Sales by Region: 2020-2025
3.2.2 Global Rotavirus Infections Drug Sales by Region: 2026-2031
3.3 Global Rotavirus Infections Drug Revenue by Region: 2020-2031
3.3.1 Global Rotavirus Infections Drug Revenue by Region: 2020-2025
3.3.2 Global Rotavirus Infections Drug Revenue by Region: 2026-2031
3.4 North America Rotavirus Infections Drug Market Facts & Figures by Country
3.4.1 North America Rotavirus Infections Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rotavirus Infections Drug Sales by Country (2020-2031)
3.4.3 North America Rotavirus Infections Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rotavirus Infections Drug Market Facts & Figures by Country
3.5.1 Europe Rotavirus Infections Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rotavirus Infections Drug Sales by Country (2020-2031)
3.5.3 Europe Rotavirus Infections Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rotavirus Infections Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Rotavirus Infections Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rotavirus Infections Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Rotavirus Infections Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rotavirus Infections Drug Market Facts & Figures by Country
3.7.1 Latin America Rotavirus Infections Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rotavirus Infections Drug Sales by Country (2020-2031)
3.7.3 Latin America Rotavirus Infections Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rotavirus Infections Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Rotavirus Infections Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rotavirus Infections Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rotavirus Infections Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rotavirus Infections Drug Sales by Type (2020-2031)
4.1.1 Global Rotavirus Infections Drug Sales by Type (2020-2025)
4.1.2 Global Rotavirus Infections Drug Sales by Type (2026-2031)
4.1.3 Global Rotavirus Infections Drug Sales Market Share by Type (2020-2031)
4.2 Global Rotavirus Infections Drug Revenue by Type (2020-2031)
4.2.1 Global Rotavirus Infections Drug Revenue by Type (2020-2025)
4.2.2 Global Rotavirus Infections Drug Revenue by Type (2026-2031)
4.2.3 Global Rotavirus Infections Drug Revenue Market Share by Type (2020-2031)
4.3 Global Rotavirus Infections Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rotavirus Infections Drug Sales by Application (2020-2031)
5.1.1 Global Rotavirus Infections Drug Sales by Application (2020-2025)
5.1.2 Global Rotavirus Infections Drug Sales by Application (2026-2031)
5.1.3 Global Rotavirus Infections Drug Sales Market Share by Application (2020-2031)
5.2 Global Rotavirus Infections Drug Revenue by Application (2020-2031)
5.2.1 Global Rotavirus Infections Drug Revenue by Application (2020-2025)
5.2.2 Global Rotavirus Infections Drug Revenue by Application (2026-2031)
5.2.3 Global Rotavirus Infections Drug Revenue Market Share by Application (2020-2031)
5.3 Global Rotavirus Infections Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Beijing Minhai Biotechnology Co Ltd
6.1.1 Beijing Minhai Biotechnology Co Ltd Company Information
6.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
6.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio
6.1.5 Beijing Minhai Biotechnology Co Ltd Recent Developments/Updates
6.2 Bharat Biotech International Ltd
6.2.1 Bharat Biotech International Ltd Company Information
6.2.2 Bharat Biotech International Ltd Description and Business Overview
6.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio
6.2.5 Bharat Biotech International Ltd Recent Developments/Updates
6.3 Biological E Ltd
6.3.1 Biological E Ltd Company Information
6.3.2 Biological E Ltd Description and Business Overview
6.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biological E Ltd Rotavirus Infections Drug Product Portfolio
6.3.5 Biological E Ltd Recent Developments/Updates
6.4 Curevac AG
6.4.1 Curevac AG Company Information
6.4.2 Curevac AG Description and Business Overview
6.4.3 Curevac AG Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Curevac AG Rotavirus Infections Drug Product Portfolio
6.4.5 Curevac AG Recent Developments/Updates
6.5 Medicago Inc
6.5.1 Medicago Inc Company Information
6.5.2 Medicago Inc Description and Business Overview
6.5.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medicago Inc Rotavirus Infections Drug Product Portfolio
6.5.5 Medicago Inc Recent Developments/Updates
6.6 Nanotherapeutics Inc
6.6.1 Nanotherapeutics Inc Company Information
6.6.2 Nanotherapeutics Inc Description and Business Overview
6.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio
6.6.5 Nanotherapeutics Inc Recent Developments/Updates
6.7 Serum Institute of India Ltd
6.7.1 Serum Institute of India Ltd Company Information
6.7.2 Serum Institute of India Ltd Description and Business Overview
6.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio
6.7.5 Serum Institute of India Ltd Recent Developments/Updates
6.8 UMN Pharma Inc
6.8.1 UMN Pharma Inc Company Information
6.8.2 UMN Pharma Inc Description and Business Overview
6.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UMN Pharma Inc Rotavirus Infections Drug Product Portfolio
6.8.5 UMN Pharma Inc Recent Developments/Updates
6.9 Wuhan Institute of Biological Products Co Ltd
6.9.1 Wuhan Institute of Biological Products Co Ltd Company Information
6.9.2 Wuhan Institute of Biological Products Co Ltd Description and Business Overview
6.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio
6.9.5 Wuhan Institute of Biological Products Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rotavirus Infections Drug Industry Chain Analysis
7.2 Rotavirus Infections Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rotavirus Infections Drug Production Mode & Process Analysis
7.4 Rotavirus Infections Drug Sales and Marketing
7.4.1 Rotavirus Infections Drug Sales Channels
7.4.2 Rotavirus Infections Drug Distributors
7.5 Rotavirus Infections Drug Customer Analysis
8 Rotavirus Infections Drug Market Dynamics
8.1 Rotavirus Infections Drug Industry Trends
8.2 Rotavirus Infections Drug Market Drivers
8.3 Rotavirus Infections Drug Market Challenges
8.4 Rotavirus Infections Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
CureVac
Medicago
Nanotherapeutics Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Institute of Biological Products Co Ltd
List of Tables
 Table 1. Global Rotavirus Infections Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rotavirus Infections Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rotavirus Infections Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rotavirus Infections Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Rotavirus Infections Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rotavirus Infections Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rotavirus Infections Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rotavirus Infections Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rotavirus Infections Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rotavirus Infections Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rotavirus Infections Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Rotavirus Infections Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rotavirus Infections Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infections Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rotavirus Infections Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rotavirus Infections Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Rotavirus Infections Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Rotavirus Infections Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Rotavirus Infections Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Rotavirus Infections Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rotavirus Infections Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Rotavirus Infections Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rotavirus Infections Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Rotavirus Infections Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rotavirus Infections Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Rotavirus Infections Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Rotavirus Infections Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rotavirus Infections Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rotavirus Infections Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rotavirus Infections Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Rotavirus Infections Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Rotavirus Infections Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rotavirus Infections Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rotavirus Infections Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rotavirus Infections Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Rotavirus Infections Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Rotavirus Infections Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rotavirus Infections Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rotavirus Infections Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rotavirus Infections Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Rotavirus Infections Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Rotavirus Infections Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rotavirus Infections Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rotavirus Infections Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rotavirus Infections Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Rotavirus Infections Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Rotavirus Infections Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rotavirus Infections Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rotavirus Infections Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Rotavirus Infections Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Rotavirus Infections Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Rotavirus Infections Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Rotavirus Infections Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rotavirus Infections Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rotavirus Infections Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Rotavirus Infections Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Rotavirus Infections Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Rotavirus Infections Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Rotavirus Infections Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Rotavirus Infections Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Rotavirus Infections Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Rotavirus Infections Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Rotavirus Infections Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rotavirus Infections Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rotavirus Infections Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Rotavirus Infections Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Rotavirus Infections Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Rotavirus Infections Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Beijing Minhai Biotechnology Co Ltd Company Information
 Table 71. Beijing Minhai Biotechnology Co Ltd Description and Business Overview
 Table 72. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product
 Table 74. Beijing Minhai Biotechnology Co Ltd Recent Developments/Updates
 Table 75. Bharat Biotech International Ltd Company Information
 Table 76. Bharat Biotech International Ltd Description and Business Overview
 Table 77. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Bharat Biotech International Ltd Rotavirus Infections Drug Product
 Table 79. Bharat Biotech International Ltd Recent Developments/Updates
 Table 80. Biological E Ltd Company Information
 Table 81. Biological E Ltd Description and Business Overview
 Table 82. Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Biological E Ltd Rotavirus Infections Drug Product
 Table 84. Biological E Ltd Recent Developments/Updates
 Table 85. Curevac AG Company Information
 Table 86. Curevac AG Description and Business Overview
 Table 87. Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Curevac AG Rotavirus Infections Drug Product
 Table 89. Curevac AG Recent Developments/Updates
 Table 90. Medicago Inc Company Information
 Table 91. Medicago Inc Description and Business Overview
 Table 92. Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Medicago Inc Rotavirus Infections Drug Product
 Table 94. Medicago Inc Recent Developments/Updates
 Table 95. Nanotherapeutics Inc Company Information
 Table 96. Nanotherapeutics Inc Description and Business Overview
 Table 97. Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Nanotherapeutics Inc Rotavirus Infections Drug Product
 Table 99. Nanotherapeutics Inc Recent Developments/Updates
 Table 100. Serum Institute of India Ltd Company Information
 Table 101. Serum Institute of India Ltd Description and Business Overview
 Table 102. Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Serum Institute of India Ltd Rotavirus Infections Drug Product
 Table 104. Serum Institute of India Ltd Recent Developments/Updates
 Table 105. UMN Pharma Inc Company Information
 Table 106. UMN Pharma Inc Description and Business Overview
 Table 107. UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. UMN Pharma Inc Rotavirus Infections Drug Product
 Table 109. UMN Pharma Inc Recent Developments/Updates
 Table 110. Wuhan Institute of Biological Products Co Ltd Company Information
 Table 111. Wuhan Institute of Biological Products Co Ltd Description and Business Overview
 Table 112. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product
 Table 114. Wuhan Institute of Biological Products Co Ltd Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Rotavirus Infections Drug Distributors List
 Table 118. Rotavirus Infections Drug Customers List
 Table 119. Rotavirus Infections Drug Market Trends
 Table 120. Rotavirus Infections Drug Market Drivers
 Table 121. Rotavirus Infections Drug Market Challenges
 Table 122. Rotavirus Infections Drug Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rotavirus Infections Drug
 Figure 2. Global Rotavirus Infections Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rotavirus Infections Drug Market Share by Type: 2024 & 2031
 Figure 4. RV-3BB Product Picture
 Figure 5. RV-625 Product Picture
 Figure 6. UMN-2001 Product Picture
 Figure 7. Rotavac-5C Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Rotavirus Infections Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Rotavirus Infections Drug Market Share by Application: 2024 & 2031
 Figure 11. Clinic
 Figure 12. Hospital
 Figure 13. Others
 Figure 14. Global Rotavirus Infections Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Rotavirus Infections Drug Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Rotavirus Infections Drug Sales (2020-2031) & (K Pcs)
 Figure 17. Global Rotavirus Infections Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Rotavirus Infections Drug Report Years Considered
 Figure 19. Rotavirus Infections Drug Sales Share by Manufacturers in 2024
 Figure 20. Global Rotavirus Infections Drug Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Rotavirus Infections Drug Players: Market Share by Revenue in Rotavirus Infections Drug in 2024
 Figure 22. Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Rotavirus Infections Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Rotavirus Infections Drug Sales Market Share by Country (2020-2031)
 Figure 25. North America Rotavirus Infections Drug Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Rotavirus Infections Drug Sales Market Share by Country (2020-2031)
 Figure 29. Europe Rotavirus Infections Drug Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Rotavirus Infections Drug Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Rotavirus Infections Drug Revenue Market Share by Region (2020-2031)
 Figure 37. China Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Rotavirus Infections Drug Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Rotavirus Infections Drug Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Rotavirus Infections Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Rotavirus Infections Drug by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Rotavirus Infections Drug by Type (2020-2031)
 Figure 59. Global Rotavirus Infections Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Rotavirus Infections Drug by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Rotavirus Infections Drug by Application (2020-2031)
 Figure 62. Global Rotavirus Infections Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Rotavirus Infections Drug Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Rhinovirus Infections Drug Market Research Report 2024
Anti Diarrheal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Anti diarrheal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Traveler s Diarrhea Market Research Report 2025
Global Antidiarrheals Market Insights Forecast to 2030
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Global Anti Infectives Market Research Report 2025
Global Poxviridae Infections Drug Market Research Report 2025
Global Rotavirus Infection Therapeutics Market Research Report 2024
Global Vaginitis Therapeutics Market Insights Forecast to 2030
Global Viral Vaccines Market Research Report 2025
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ritonavir Drug Market Research Report 2024
Global Human Papillomavirus Infection Drug Market Research Report 2025
Global Urinary Tract Infection Therapeutics Market Research Report 2025
Drugs For Travelers Diarrhea TD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmic Anti Infective Drugs Market Research Report 2025
Global West Nile Virus Infections Medicine Market Research Report 2025
Global Respiratory Infection Diagnostic Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions